Cubist Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 69   

Articles published

CBST 73.59 +0.22 (0.30%)
price chart
Cubist announces results from CB-5945 Phase 2 studies on chronic non-cancer ...
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the results from the Phase 2 studies of CB-5945 (formerly ADL5945) in patients with chronic non-cancer pain and opioid-induced constipation (OIC) will be presented at the 31st Annual ...
Related articles »  
Ra Pharma Pours $8.6M Into Discovery Tech and New Rare-Disease Drug
Today Ra Pharmaceuticals CEO Doug Treco will make a presentation at a conference in Las Vegas that will cap off the Cambridge, MA-based company's weeklong unveiling. On May 16, Ra announced it had closed an $8.6 million tranche of its $27 million ...
Hutch, UW Scientists Find Elusive Cancers With Adaptive Diagnostic
So if the Seattle scientists can go on to reproduce these findings in other cancers, it could open the door to a potentially lucrative new diagnostic line of business for Adaptive Biotechnologies, a company that has already made some headway by ...
Related articles »  
Theraclone Passes First Clinical Test with Flu-Fighting Antibody
The Seattle-based biotech company is announcing today that it passed its first clinical trial with an antibody drug designed to fight a wide variety of flu strains.
Related articles »  
Peripheral Opioid Receptor Antagonist CB-5945 Improves Bowel Motility
HONOLULU, HI� �Significant, clinically meaningful improvements in spontaneous bowel movement (SBM) frequency were observed after CB-5945 treatment,� stated Lee Techner, DPM, from Cubist Pharmaceuticals, Lexington, MA, at the American Pain ...
From MIT Entrepreneur to Tea Party Leader: The Thomas Massie Story
Yet even more compelling than the company is its founder, a young engineering whiz from MIT named Thomas Massie. Over the years, that whiz kid developed many other passions besides building computer interfaces and running a tech company. Things ...
Related articles »  
Buying SD's Ortiva Wireless Adds Video Optimization to Allot's Tools
In response to a question about Ortiva's local operations, Zionts says the company plans to keep its office in University City post-acquisition, and will likely grow beyond its current 41 employees.
Related articles »  
InsightSquared Scores $4.5M, Looks to Bring Business Intelligence to the Masses
Finally, a tech company that's not all about big data. In fact, this one is about lots of little bits of �idiosyncratic, messy data,� says its founder.
Related articles »  
Who's on Biotech's Endangered Species List? Mid-Sized Drugmakers
�If you are a Big Pharma company facing a patent cliff, you really have a huge revenue gap to fill, and small companies don't really help you.
Related articles »  
Never Let Anyone Make You a Carrot
The day is coming when a single carrot, freshly observed, will set off a revolution.� �Paul Cezanne. A couple of years ago my sister told me a story about how she came home from work to find her husband and then 5-year-old daughter playing �house� with ...